ReP USP - Resultado da busca

Artigo de periodico
Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems (2021)
Luiz, Marcela Tavares; Viegas, Juliana Santos Rosa ; Abriata, Juliana Palma; Viegas, Felipe; Vicentini, Fabiana Testa Moura-de-Carvalho ; Bentley, Maria Vitória Lopes Badra ; Chorilli, Marlus; Marchetti, Juliana Maldonado; Tapia-Blacido, Delia Rita
Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: FCFRP, FFCLRP
Subjects: NANOTECNOLOGIA, NANOPARTÍCULAS, DESIGNS (CONFIGURAÇÕES COMBINATÓRIAS), SISTEMAS DE DISTRIBUIÇÃO DE MEDICAMENTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZ, Marcela Tavares et al. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, v. 165, p. 127-148, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2021.05.011. Acesso em: 14 nov. 2024.
APA
Luiz, M. T., Viegas, J. S. R., Abriata, J. P., Viegas, F., Vicentini, F. T. M. -de-C., Bentley, M. V. L. B., et al. (2021). Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems. European Journal of Pharmaceutics and Biopharmaceutics, 165, 127-148. doi:10.1016/j.ejpb.2021.05.011
NLM
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Vancouver
Luiz MT, Viegas JSR, Abriata JP, Viegas F, Vicentini FTM-de-C, Bentley MVLB, Chorilli M, Marchetti JM, Tapia-Blacido DR. Design of experiments (DoE) to develop and to optimize nanoparticles as drug delivery systems [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2021 ; 165 127-148.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejpb.2021.05.011
Artigo de periodico
Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells (2021)
Miranda, Mariza Abreu ; Gaspari, Priscyla Daniely Marcato ; Mondal, Arindam; Chowdhury, Nusrat; Gebeyehu, Aragaw; Surapaneni, Sunil Kumar; Bentley, Maria Vitória Lopes Badra ; Amaral, Robson; Pan, Chong-Xian; Singh, Mandip
Source: Materials Science and Engineering C. Unidade: FCFRP
Subjects: NEOPLASIAS DA BEXIGA, MEDICAMENTO, PACIENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIRANDA, Mariza Abreu et al. Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells. Materials Science and Engineering C, v. 119, p. 1-12, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.msec.2020.111460. Acesso em: 14 nov. 2024.
APA
Miranda, M. A., Gaspari, P. D. M., Mondal, A., Chowdhury, N., Gebeyehu, A., Surapaneni, S. K., et al. (2021). Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells. Materials Science and Engineering C, 119, 1-12. doi:10.1016/j.msec.2020.111460
NLM
Miranda MA, Gaspari PDM, Mondal A, Chowdhury N, Gebeyehu A, Surapaneni SK, Bentley MVLB, Amaral R, Pan C-X, Singh M. Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells [Internet]. Materials Science and Engineering C. 2021 ; 119 1-12.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.msec.2020.111460
Vancouver
Miranda MA, Gaspari PDM, Mondal A, Chowdhury N, Gebeyehu A, Surapaneni SK, Bentley MVLB, Amaral R, Pan C-X, Singh M. Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells [Internet]. Materials Science and Engineering C. 2021 ; 119 1-12.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.msec.2020.111460
Artigo de periodico
Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine (2021)
Leite, Marcel Nani; Viegas, Juliana Santos Rosa ; Praça, Fabíola ; Paula, Natália Aparecida de ; Ramalho, Leandra Naíra Zambelli; Bentley, Maria Vitória Lopes Badra ; Frade, Marco Andrey Cipriani
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FÁRMACOS, PELE, ANTINEOPLÁSICOS, FIBROBLASTOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE, Marcel Nani et al. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, v. 160, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2021.105769. Acesso em: 14 nov. 2024.
APA
Leite, M. N., Viegas, J. S. R., Praça, F., Paula, N. A. de, Ramalho, L. N. Z., Bentley, M. V. L. B., & Frade, M. A. C. (2021). Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine. European Journal of Pharmaceutical Sciences, 160. doi:10.1016/j.ejps.2021.105769
NLM
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Vancouver
Leite MN, Viegas JSR, Praça F, Paula NA de, Ramalho LNZ, Bentley MVLB, Frade MAC. Ex vivo model of human skin (hOSEC) for assessing the dermatokinetics of the anti-melanoma drug dacarbazine [Internet]. European Journal of Pharmaceutical Sciences. 2021 ; 160[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.ejps.2021.105769
Artigo de periodico
TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy (2021)
Suzuki, Isabella Luiz; Araújo, Margarete Moreno de ; Bagnato, Vanderlei Salvador ; Bentley, Maria Vitória Lopes Badra
Source: Journal of Controlled Release. Unidades: IFSC, FCFRP
Subjects: NANOPARTÍCULAS, PSORÍASE, RNA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUZUKI, Isabella Luiz et al. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy. Journal of Controlled Release, v. 338, p. 316-329, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.jconrel.2021.08.039. Acesso em: 14 nov. 2024.
APA
Suzuki, I. L., Araújo, M. M. de, Bagnato, V. S., & Bentley, M. V. L. B. (2021). TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy. Journal of Controlled Release, 338, 316-329. doi:10.1016/j.jconrel.2021.08.039
NLM
Suzuki IL, Araújo MM de, Bagnato VS, Bentley MVLB. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy [Internet]. Journal of Controlled Release. 2021 ; 338 316-329.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jconrel.2021.08.039
Vancouver
Suzuki IL, Araújo MM de, Bagnato VS, Bentley MVLB. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy [Internet]. Journal of Controlled Release. 2021 ; 338 316-329.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.jconrel.2021.08.039

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Subjects

Indexado em

Non normalized affiliation